These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 8145672

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. New treatment for cystic fibrosis.
    Kuhn RJ.
    Am Pharm; 1994 Feb; NS34(2):16-8. PubMed ID: 8166040
    [No Abstract] [Full Text] [Related]

  • 5. Consensus conference: practical applications of Pulmozyme. September 22, 1993.
    Ramsey BW, Dorkin HL.
    Pediatr Pulmonol; 1994 Jun; 17(6):404-8. PubMed ID: 8090614
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis.
    Hubbard RC, McElvaney NG, Birrer P, Shak S, Robinson WW, Jolley C, Wu M, Chernick MS, Crystal RG.
    N Engl J Med; 1992 Mar 19; 326(12):812-5. PubMed ID: 1538726
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Nebulised bronchodilators, antibiotics and rhDNase for children with cystic fibrosis.
    Spencer DA.
    Thorax; 1997 Apr 19; 52 Suppl 2(Suppl 2):S89-91. PubMed ID: 9155860
    [No Abstract] [Full Text] [Related]

  • 11. Nebulised bronchodilators, corticosteroids, and rhDNase in adult patients with cystic fibrosis.
    Conway SP, Watson A.
    Thorax; 1997 Apr 19; 52 Suppl 2(Suppl 2):S64-8. PubMed ID: 9155855
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Pulmozyme (Dornase alfa)].
    Töglhofer W.
    Wien Klin Wochenschr; 1994 Apr 19; 106(8):253-6. PubMed ID: 8023518
    [No Abstract] [Full Text] [Related]

  • 14. Statistical analysis of the long-term effects of recombinant human deoxyribonuclease on pulmonary function in cystic fibrosis patients.
    Chen JJ, Hamilton SA.
    J Biopharm Stat; 2000 Aug 19; 10(3):287-97. PubMed ID: 10959912
    [Abstract] [Full Text] [Related]

  • 15. Aerosolized dornase alpha (rhDNase) in cystic fibrosis.
    Bates RD, Nahata MC.
    J Clin Pharm Ther; 1995 Dec 19; 20(6):313-5. PubMed ID: 8847368
    [Abstract] [Full Text] [Related]

  • 16. [Cystic fibrosis. Current indications for nebulized treatments: antibiotics and DNase].
    Sardet-Frismand A.
    Rev Mal Respir; 1999 Jan 19; 16 Suppl 3():S131-2. PubMed ID: 10088286
    [No Abstract] [Full Text] [Related]

  • 17. [Perspective of use of rhDNase and new therapeutics for cystic fibrosis].
    Navarro J, Munck A.
    Arch Pediatr; 1995 Jul 19; 2(7):682-4. PubMed ID: 7663661
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group.
    O'Donnell AE, Barker AF, Ilowite JS, Fick RB.
    Chest; 1998 May 19; 113(5):1329-34. PubMed ID: 9596315
    [Abstract] [Full Text] [Related]

  • 20. [Current therapeutic agents: dornase alfa].
    Baran D, Sternon J.
    Rev Med Brux; 1997 Feb 19; 18(1):37-40. PubMed ID: 9132917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.